Higher-risk breast cancer in women aged 80 and older: Exploring the effect of treatment on survival
- PMID: 34274566
- PMCID: PMC8319352
- DOI: 10.1016/j.breast.2021.07.005
Higher-risk breast cancer in women aged 80 and older: Exploring the effect of treatment on survival
Abstract
Background: To understand the association between various treatments and survival for older women with higher-risk breast cancer when controlling for patient and tumor factors.
Materials and methods: We conducted a retrospective, population-based study. Women aged 80 years or older and diagnosed between 2004 and 2017 with non-metastatic, higher-risk breast cancer were identified form the provincial cancer registry in Alberta, Canada. Higher-risk was defined as any of following: T3/4, node positive, human epidermal factor receptor-2 (Her2) positive or triple negative disease. Treatments were surgery, radiotherapy and systemic therapy (hormonal therapy, and/or chemotherapy and/or trastuzumab) or a combination of the previous. Cox regression models were used to examine the association between treatments and breast cancer specific survival (BCSS) and overall survival (OS).
Results: 1369 patients were included. The median age was 84 years. 332 (24%) of women had T3-T4 tumors, 792 (58%) had nodal involvement, 130 (10%) had Her2 positive tumors, 124 (9%) had triple negative tumors. After a median follow-up of 35 months, 29.5% of patients died of breast cancer whereas 34.2% died from other causes. Patients had a lower adjusted hazard for BCSS if they had surgery (hazard ratio [HR] = 0.37 95% confidence interval [CI]: 0.27, 0.51), or systemic therapy (HR = 0.75, 95%CI: 0.58, 0.98). Patients had an increased probability of breast cancer death in the first 5 years after diagnosis compared to death from other causes.
Conclusions: Surgery and systemic therapy were associated with longer BCSS and OS. This suggests that maximizing treatments might benefit higher-risk patients.
Keywords: Breast cancer death; Her2 positive; Locally advanced; Nonagenarians; Octogenarians; Triple negative.
Copyright © 2021 The Authors. Published by Elsevier Ltd.. All rights reserved.
Conflict of interest statement
Declarations of competing interest LB has received an honorarium from Genentech and travel support from Elekta. Other authors, none.
Figures
References
-
- Vincent G.K., Velkoff V.A. 2010. The next four decades: the older population in the United States: 2010 to 2050. Population estimates and projections.http://www.census.gov/prod/2010pubs/p25-1138.pdf Accessed on February 19th 2021.
-
- Mandelblatt J.S., Hadley J., Kerner J.F. Patterns of breast carcinoma treatment in older women: patient preference and clinical and physical influences. Cancer. 2000;89(3):561–573. - PubMed
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Medical
Research Materials
Miscellaneous
